News Releases

ITUS Corporation Terminates At-The-Market Offering

December 12, 2017

ITUS Will Present Data on Early Cancer Detection Technology at ASCO-SITC Symposium

December 6, 2017

ITUS Receives Notice of Allowance for Second Key Cancer Technology Patent

November 28, 2017

ITUS Conference Call Recording Available on Company Website

November 22, 2017

ITUS Will Hold Conference Call to Discuss its CAR-T Cancer Therapeutics Program

November 21, 2017

ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center

November 20, 2017

ITUS Corporation Licenses CAR-T Technology from The Wistar Institute

November 14, 2017

ITUS Corporation Pays Off Secured Debenture

October 27, 2017

ITUS Receives Notice of NASDAQ Continued Listing Compliance

October 3, 2017

ITUS Corporation Completes At-the-Market Offering

October 2, 2017

1
2
3
4
Next »

Latest News & Events

Jun 10, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Read More...

Jun 9, 2025

Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025

Read More...

Jun 3, 2025

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview

Read More...